ERYTECH Reports Business and Financial Update for the First Half of 2016 Post author:admERY Post published:September 6, 2016 Post category:Newsroom ERYTECH Pharma today provided a business update and reported its financial results for the six month period ended June 30, 2016. You Might Also Like ERYTECH Pharma’s sickle cell treatment receives positive opinion for Orphan Drug Designation from the European Medicines Agency June 13, 2012 PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences September 5, 2023 ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 25, 2021 May 25, 2021
ERYTECH Pharma’s sickle cell treatment receives positive opinion for Orphan Drug Designation from the European Medicines Agency June 13, 2012
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences September 5, 2023